This may have been posted before but my LinkedIn is usually a week old. Maybe worth listening in to however,
Here is Spark Plus company bio:
"Spark Plus hosts non deal roadshows for listed companies that may not have the best coverage in the Asia-Pacific region. Spark Plus provides the listed companies with access to investors via non deal roadshow luncheons. With an extensive database of hedge funds, family offices, mutual funds, private banks, and brokers, Spark Plus can provide connectivity to the relevant connections."
Why are we investing time into non deal roadshows. Surely 20 years at the helm you would have built up the right connections that we dont need Spark plus??
YouTube interviews would be better than this. SparkPlus can't even keep their website updated with past and upcoming events.
We need a partner that can commit funds to lock in and transition our clinical pipeline to more than just a pipe dream. I would take partnering now and potentially losing future value than our current trajectory. A bird in the hand is better than two in the bush, or a secured and financed clinical pathway is better than meandering down the road of ill advised cap raises.
What frustrates me is that the company states they are reviewing all expenditure and being prudent, but are stumping up funds to appear on these Shit+ roadshows.
Other bios are up 10-20% since recent monthly lows, yesterdays trading would instill some confidence if there was any volume to it. I'm putting it out there we are the lowest traded (by volume and market cap) stock on the asx that has a potential best in class drug which is within reach of commercialization. Why is this?
How do stocks build more confidence? IMO more communication and a transparent strategy. We need to start with this. I understand the sentiment of a timeline has been communicated and we need to be patient, but really when you have a timeline with some bars across a year thats not even broken into quarters what can you hold the company to account on.
A cap raise at this level without clarity on where we are going beyond "trials start soon" will be a punch in the gut
ANP Price at posting:
8.5¢ Sentiment: Buy Disclosure: Held
